Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-19-Speech-3-380-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-01-19"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20110119.20.3-380-000"2
lpv:hasSubsequent	lp_eu:2011-01-19-Speech-3-380-5002
lpv:speaker	lp:Diogo Feio2
lpv:spokenAs	substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 unknown; Partido Popular (2009-07-14--2014-06-30)3 member; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2009-09-16--2014-06-30)3 member; ECON (2009-07-16--2012-01-18)3 member; EPP (2009-07-14--2014-06-30)3 substitute; AFET (2009-07-16--2012-01-18)3 substitute; Special Committee on the Financial, Economic and Social Crisis (2009-10-08--2011-07-31)3
lpv:translated text	"This case, of more than ten years’ standing, has caused considerable financial losses to the company, because it has still not obtained a final response from the Commission relating to its misunderstanding with the German authorities. It is essential that all medical devices sold in the EU comply with Union law and, for the defence and protection of its consumers, satisfy safety standards. However, it is up to the Commission to take the necessary measures to bring this case to a conclusion, since disputes need to be resolved in good time."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph